National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 23391 [2021-09236]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 83 / Monday, May 3, 2021 / Notices
Dated: April 23, 2021.
Janet Woodcock,
Acting Commissioner of Food and Drugs.
Dated: April 27, 2021.
Xavier Becerra,
Secretary, Department of Health and Human
Services.
[FR Doc. 2021–09134 Filed 4–30–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Request for Information (RFI)
Developing the National Public Health
Strategy for the Prevention and
Control of Vector-Borne Diseases in
Humans; Correction
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice; correction.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
Correction
In the Federal Register of April 27,
2021, in FR Doc. 2021–08167, on page
22214, in the third column, correct the
ADDRESSES caption to read:
ADDRESSES: Public comments should be
submitted online at https://
www.regulations.gov. All submissions
must be submitted to the Docket named
HHS–OASH–2021–0012 to ‘‘Request for
Information (RFI) from Non-Federal
Stakeholders: Developing the National
Public Health Strategy for the
Prevention and Control of Vector-Borne
Diseases in Humans.’’ Comments
submitted electronically, including
attachments, will be posted to the
docket unchanged and available for
view by the public. Evidence and
information supporting your comment
can be submitted as attachments. Please
provide your contact information or
Jkt 253001
Kristen Honey,
Chief Data Scientist, Senior Advisor, Office
of the Assistant Secretary for Health, U.S.
Department of Health and Human Services.
BILLING CODE 4150–28–P
The Office of the Assistant
Secretary for Health published a
document in the Federal Register of
April 27, 2021, requesting comments be
sent via www.regulations.gov with a
docket number of HHS–OASH–2021–
0001. The referenced docket number
was incorrect and also inadvertently
omitted two additional questions on
page 22215.
FOR FURTHER INFORMATION CONTACT: Dr.
Kristen Honey, Chief Data Scientist,
Senior Advisor, Office of the Assistant
Secretary for Health, Department of
Health and Human Services, 200
Independence Avenue SW, Washington,
DC 20201, vectorbornedisease@hhs.gov,
(202) 853–7680.
SUPPLEMENTARY INFORMATION:
20:34 Apr 30, 2021
5. How can insights from climate change be
incorporated into the development of a
national strategy?
6. How should low-income and vulnerable
populations be addressed in the national
strategy?
[FR Doc. 2021–09241 Filed 4–30–21; 8:45 am]
SUMMARY:
VerDate Sep<11>2014
organization name on the web-based
form for possible follow up from HHS.
There is a 5,000 character limit on
comments and maximum number (10)
of attached files and maximum size (10
MB) of each attached file.
In the Federal Register of April 27,
2021, in FR Doc. 2021–08167, on page
22215, in the second column, after
question number ‘‘4.’’ should be two
additional questions to read as follows:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Clinical Trials
Review Committee.
Date: June 24, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Keary A. Cope, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–A,
Bethesda, MD 20892–7924, (301) 827–7912,
copeka@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
23391
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 28, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–09236 Filed 4–30–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Biology Structure and Regeneration
Study Section.
Date: June 2–4, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yanming Bi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, (301) 451–
0996, ybi@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA RM20–
022: Faculty Institutional Recruitment for
Sustainable Transformation (FIRST) Program.
Date: June 2–3, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia K Ortenberg, Ph.D..
Scientific Review Officer. Center for
Scientific Review. National Institutes of
Health. 6701 Rockledge Drive, Room 3108,
MSC 7816, Bethesda, MD 20892, (301) 827–
7189, femiaee@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
E:\FR\FM\03MYN1.SGM
03MYN1
]]>Agencies
[Federal Register Volume 86, Number 83 (Monday, May 3, 2021)]
[Notices]
[Page 23391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09236]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
Clinical Trials Review Committee.
Date: June 24, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Keary A. Cope, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
209-A, Bethesda, MD 20892-7924, (301) 827-7912, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: April 28, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-09236 Filed 4-30-21; 8:45 am]
BILLING CODE 4140-01-P
